Results 151 to 160 of about 167,619 (306)

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA). [PDF]

J Biol Chem, 2023
Torres-Paris C, Chen Y, Xiao L, Song HJ, Chen P, Komives EA.   +5 more
europepmc   +1 more source

Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. [PDF]

, 1982
E G Levin, David J. Loskutoff
openalex   +1 more source

Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database

The Journal of Dermatology, Volume 52, Issue 5, Page 841-854, May 2025.
Abstract Atopic dermatitis, psoriasis, alopecia areata, and vitiligo have been associated with comorbid conditions, including infections, malignancies, and cardiovascular diseases. This study evaluated the prevalence and incidence rates of these comorbidities in patients from Japan.
Yue Ma, Motohiko Chachin, Tomohiro Hirose, Kouki Nakamura, Nanzhi Shi, Shintaro Hiro, Shinichi Imafuku   +6 more
wiley   +1 more source

A biochemical study of tissue type plasminogen activator in bovine milk [PDF]

, 2007
Thesis (MSc)--University of Stellenbosch, 2007.ENGLISH ABSTRACT: This study describes: 1. The isolation and the purification of tissue type plasminogen activator and urokinase plasminogen activator in bovine milk. 2.
Cilliers, Frans Pieter
core  

Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer. [PDF]

Matrix Biol Plus, 2023
Micalet A, Tappouni LJ, Peszko K, Karagianni D, Lam A, Counsell JR, Quezada SA, Moeendarbary E, Cheema U.   +8 more
europepmc   +1 more source

Natural products targeting tumour angiogenesis

British Journal of Pharmacology, Volume 182, Issue 10, Page 2094-2136, May 2025.
Abstract Tumour angiogenesis is the formation of new blood vessels to support the growth of a tumour. This process is critical for tumour progression and metastasis, making it an attractive approach to cancer therapy. Natural products derived from plants, animals or microorganisms exert anti‐angiogenic properties and can be used to inhibit tumour ...
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth   +2 more
wiley   +1 more source

Editor's choice : European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia

, 2020
A
Acosta, Stefan, Azuma, Nobuyoshi, Bastos Gonçalves, Frederico, Björck, Martin, Boyle, Jonathan R., Chakfé, Nabil, Choke, Edward T. C., Cochennec, Frederic, Cohnert, Tina U., de Borst, Gert J., Document Reviewers, Earnshaw, Jonothan J., ESVS Guidelines Committee, Fitridge, Robert A., Forbes, Thomas L., Hamady, Mohamad S., Hinchliffe, Robert, Jongkind, Vincent, Kakkos, Stavros K., Koelemay, Mark J. W., Koncar, Igor, Lindholt, Jes S., Mani, Kevin, Menyhei, Gabor, Munoz, Alberto, Müller-Hülsbeck, Stefan, Rai, Kumud, Sebastian Debus, E., Svetlikov, Alexei V., Tshomba, Yamume, Tulamo, Riikka, van den Berg, Jos C., Vega de Ceniga, Melina, Vermassen, Frank   +33 more
core   +2 more sources

Cell Biology of Cancer Peritoneal Metastasis: Multiclonal Seeding and Peritoneal Tumor Microenvironment

Cancer Science, Volume 116, Issue 5, Page 1171-1180, May 2025.
We summarize recent findings on the cell biological aspects of peritoneal metastasis and potential therapeutic target molecules. We focus on the molecular mechanisms underlying cluster/spheroid formation in multiclonal peritoneal metastasis and cancer–stroma interactions within the peritoneal tumor microenvironment. ABSTRACT Peritoneal metastasis, also
Hideki Yamaguchi, Makoto Miyazaki
wiley   +1 more source

Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. [PDF]

, 1986
Robert L. Medcalf, Robert I. Richards, Robert Crawford, John A. Hamilton   +3 more
openalex   +1 more source

Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2647-2657, May 2025.
Abstract Objective Roux‐en‐Y gastric bypass (RYGB) surgery has been shown to lead to favourable health outcomes in obese patients. However, the molecular changes that occur and how they relate to clinical measures are poorly understood. Here, we characterise the proteomic alterations that occur in plasma of RYGB patients before and 9 months after ...
Hasnain Ahmed, Marco F. Fernandes, Kazim Abbas, Silvia A. Synowsky, Sally L. Shirran, Ramzi A. Ajjan, Alan J. Stewart   +6 more
wiley   +1 more source